The IPO Buzz: Generate Biomedicines Prices IPO at $16 Mid-Point & Stock Falls in NASDAQ Debut
AI-driven Generate Biomedicines (GENB) priced its IPO at $16.00 – the mid-point of its range – and sold 25 million shares – the number in the prospectus – to raise $400 million on Thursday night, Feb. 26, 2026. Generate Biomedicines (GENB) shares slid $1.00 to start trading at $15.00 on NASDAQ shortly before 1 p.m. EST […]
February 27, 2026 Read More